Spots Global Cancer Trial Database for salivary gland adenocarcinoma
Every month we try and update this database with for salivary gland adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Title XELOX FOR SALIVARY GLAND CANCERS | NCT00101075 | Head and Neck C... | Capecitabine Oxaliplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | NCT00897793 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer | venipuncture radiation thera... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer | NCT00004163 | Head and Neck C... | Trastuzumab | 18 Years - | Dana-Farber Cancer Institute | |
| Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy | NCT01156142 | Head and Neck C... Mucositis Oral Complicati... Pain | doxepin hydroch... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Title XELOX FOR SALIVARY GLAND CANCERS | NCT00101075 | Head and Neck C... | Capecitabine Oxaliplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer | NCT00126607 | High-grade Sali... Recurrent Saliv... Salivary Gland ... Salivary Gland ... Salivary Gland ... Stage IVA Saliv... Stage IVB Saliv... Stage IVC Saliv... | trastuzumab laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | NCT00027534 | Breast Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Ovarian Cancer Pancreatic Canc... Testicular Germ... | TRICOM-CEA(6D) | 18 Years - | Duke University | |
| Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer | NCT00004163 | Head and Neck C... | Trastuzumab | 18 Years - | Dana-Farber Cancer Institute | |
| Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery | NCT01220583 | Head and Neck C... | cisplatin 3-dimensional c... intensity-modul... | 18 Years - | Radiation Therapy Oncology Group | |
| RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma | NCT00101972 | Cancer | monoclonal anti... | 18 Years - | MacroGenics | |
| Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery | NCT00003744 | Head and Neck C... | gemcitabine | 18 Years - | Dana-Farber Cancer Institute | |
| Family Quality of Life Among Families With a Member Who is a Cancer Patient | NCT00544336 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Prostate Cancer Solid Tumor | questionnaire a... survey administ... quality-of-life... | 21 Years - | Vanderbilt-Ingram Cancer Center | |
| Title XELOX FOR SALIVARY GLAND CANCERS | NCT00101075 | Head and Neck C... | Capecitabine Oxaliplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer | NCT00002632 | Head and Neck C... | paclitaxel | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer | NCT00004163 | Head and Neck C... | Trastuzumab | 18 Years - | Dana-Farber Cancer Institute | |
| Gene Therapy in Treating Patients With Cancer | NCT00004178 | Cancer | therapeutic aut... | 18 Years - | Roger Williams Medical Center | |
| Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery | NCT00003744 | Head and Neck C... | gemcitabine | 18 Years - | Dana-Farber Cancer Institute | |
| Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer | NCT00851253 | Head and Neck C... | stereotactic ra... | 18 Years - | Boston Medical Center | |
| Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy | NCT01156142 | Head and Neck C... Mucositis Oral Complicati... Pain | doxepin hydroch... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor | NCT00079079 | Head and Neck C... | carboplatin cisplatin gemcitabine hyd... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma | NCT00101972 | Cancer | monoclonal anti... | 18 Years - | MacroGenics |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
